pharmacokinetics of glp 1 receptor agonists Population the GIP/GLP agonist tirzepatide - Schneck - 2024 - CPT: Pharmacometrics & Systems Pharmacology Evaluation of the pharmacokinetics of

IGF-1 LR3 contains an arginine substitution at position 3 and a 13-amino acid extension, giving it a 20-30 hour half-life versus 10 minutes for native IGF-1

Vinceti et al., 2019), whereas a rather low level of GPX3 expression was reported for the rat choroid plexus (Kratzer et al., 2013)

Furukawa RE, Polse KA

This process, along with GCL inhibition and the formation of mixed disulfides between GSH and protein sulfhydryl, concurred to a steady-state decrement of free GSH concentration and, consequently, to an intracellular redox state shift toward more oxidizing conditions, which could be required for avoiding fast reduction of oxidized cysteines allowing the upstream ROS-induced autophagic stimulus to be propagated